Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)

ClinicalTrials.gov ID: NCT01454349

Public ClinicalTrials.gov record NCT01454349. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 3:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Dose-Escalation, Multicenter Safety and Efficacy Study of a Single Transrectal Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)

Study identification

NCT ID
NCT01454349
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Sophiris Bio Corp
Industry
Enrollment
40 participants

Conditions and interventions

Interventions

  • PRX302 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
Feb 28, 2013
Completion
Jul 31, 2013
Last update posted
Aug 20, 2013

2011 – 2013

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
South Orange County Medical Research Center Laguna Hills California 92653
Atlantic Urology Medical Group Long Beach California 90806
California Professional Research Newport Beach California 92660
University of Colorado Denver Aurora Colorado 80045
South Florida Medical Research Aventura Florida 33180
Northwestern University Chicago Illinois 60611
The Iowa Clinic West Des Moines Iowa 50266
Accumed Research Associates Garden City New York 11530
University Urology Associates New York New York 10016
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601
TriState Urological Services Cincinnatti Ohio 45212
Urologic Consultants of SE Pennsylvania Bala-Cynwyd Pennsylvania 19004
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Research Across America Carrollton Texas 75010
UT Southwestern Medical Center Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01454349, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01454349 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →